Navigation Links
SciClone To Present At Two Investor Conferences On September 10, 2015
Date:8/27/2015

FOSTER CITY, Calif., Aug. 27, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview and business update at two investor conferences on September 10, 2015, in New York City.

  • 22nd Annual NewsMakers in the Biotech Industry: presentation at 11:30 am ET at the Millennium Broadway Hotel.
  • Rodman & Renshaw Annual Global Investment Conference: presentation at 3:00 pm ET at the St. Regis Hotel.
  • To access the live audio webcast of these presentations, please log on through a link located in the Investor Relations section of SciClone's website at www.sciclone.com, under the Calendar of Events tab. A replay of the webcast will be available one hour after the conclusion of the live events.

    About SciClone SciClone Pharmaceuticals is a revenue-generating, specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. SciClone's proprietary lead product, ZADAXIN® (thymalfasin), is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), and certain cancers, and as a vaccine adjuvant, according to the local regulatory approvals. The Company has successfully in-licensed and commercialized products with the potential to become future market leaders and to drive the Company's long-term growth, including DC Bead®, a novel treatment for liver cancer. Through its promotion business with pharmaceutical partners, SciClone also markets multiple branded products in China which are therapeutically differentiated. SciClone is a publicly-held corporation based in Foster City, California, and trades on the NASDAQ Global Select Market under the symbol SCLN. For additional information, please visit www.sciclone.com.

    Forward-Looking Statements This press release contains forward-looking statements regarding expected financial results and expectations. Readers are urged to consider statements that include the words "may," "will," "would," "could," "should," "might," "believes," "estimates," "projects," "potential," "expects," "plans," "anticipates," "intends," "continues," "forecast," "designed," "goal," "unaudited," "approximately" or the negative of those words or other comparable words to be uncertain and forward-looking. These statements are subject to risks and uncertainties that are difficult to predict and actual outcomes may differ materially.  Please also refer to other risks and uncertainties described in SciClone's filings with the SEC. All forward-looking statements are based on information currently available to SciClone and SciClone assumes no obligation to update any such forward-looking statements.

    SciClone, SciClone Pharmaceuticals, the SciClone Pharmaceuticals design, the SciClone logo and ZADAXIN are registered trademarks of SciClone Pharmaceuticals, Inc. in the United States and numerous other countries.Corporate Contacts Wilson W. Cheung

    Jane GreenChief Financial Officer Investors/Media650.358.3434650.358.1447wcheung@sciclone.com 

    jgreen@sciclone.comLogo - http://photos.prnewswire.com/prnh/20150722/240358LOGO

     


    '/>"/>
    SOURCE SciClone Pharmaceuticals, Inc.
    Copyright©2015 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Lexicon Announces Telotristat Etiprate Data To Be Presented At European Cancer Congress
    2. Henry Schein To Present At Three Investor Conferences In September
    3. DelMar Pharmaceuticals to Present at the 17th Annual Rodman & Renshaw Global Investment Conference on September 9, 2015
    4. PDA Presents its Perspective on the US FDA Quality Metrics Draft Guidance at Public Meeting
    5. Mirati Therapeutics To Present Preclinical And Clinical Data At The IASLC 16th World Conference On Lung Cancer
    6. Misonix to Present at the Sidoti Emerging Growth Conference
    7. Rock Creek Pharmaceuticals to Present at the Annual BioPharm America International Partnering Conference
    8. Trovagene to Present Clinical Data and Capabilities of Its Urine-Based Liquid Biopsy Platform at the 7th Annual Next Generation Dx Summit
    9. Instrumentation Review 2015 - Presents Strategic Assessments of Current and Emerging Suppliers
    10. Rock Creek Pharmaceuticals to Present at the 17th Annual Rodman & Renshaw Global Investment Conference
    11. Bayer to Present Latest Research at the National Hemophilia Foundation Annual Meeting in Dallas
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2020)... (PRWEB) , ... August 27, 2020 , ... The flu season is right round the ... get well equipped with all the necessary measures before it begins to harbor its effects ... increasing, and it is leaving a huge impact on our lives. Hence it has become ...
    (Date:8/27/2020)... , ... August 27, 2020 , ... Bridge To A ... Dr. Friedman is an adult and pediatric neuro-oncologist who serves on the Board of ... an educator at Duke University Medical School. , Internationally recognized, Dr. Friedman is a ...
    (Date:8/26/2020)... ... 2020 , ... AseptiScope, a privately funded San Diego, California based, clinical innovation ... Outlook. , “AseptiScope is pleased to receive this recognition,” said Kelly Powers, ... on their hands, goggles on their eyes, covers on their shoes, and gowns on ...
    Breaking Medicine Technology:
    (Date:9/3/2020)... ... 03, 2020 , ... MemoryCare.com, a comprehensive resource for caregivers ... Facilities in Louisville, KY. The guide identifies 17 memory care communities based on ... Alzheimer’s Association , 5.6 million people age 65 and older are living ...
    (Date:9/1/2020)... ... 2020 , ... Feeding Matters , the first organization in the world ... is pleased to announce that the U.S. Centers for Disease Control and Prevention (CDC) ... next edition of the U.S. International Classification of Diseases (ICD ) on October ...
    (Date:8/31/2020)... , ... August 31, 2020 , ... Just found out your dear friend has cancer? ... when your friend or family member shares their diagnosis. Once the shock wears off, the ... the wrong thing? What are the best ways to help? Words are failing me. I’m ...
    (Date:8/31/2020)... IRVINE, Calif. (PRWEB) , ... August 31, 2020 ... ... providers of business support services to dental groups in the United States, today ... serving the community of Beaumont, CA. , Patients will enjoy convenient hours, ...
    (Date:8/31/2020)... ... August 31, 2020 , ... Bonde Innovations, LLC, ... with advanced heart failure, today announced that the company has been awarded a ... from the National Heart, Lung, and Blood Institute of the National Institutes of ...
    Breaking Medicine News(10 mins):